NexgenRx Inc. (NEGXF)
OTCMKTS · Delayed Price · Currency is USD
0.2800
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
NexgenRx Revenue
NexgenRx had revenue of 4.35M CAD in the quarter ending June 30, 2025, with 8.73% growth. This brings the company's revenue in the last twelve months to 16.99M, up 12.03% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.
Revenue (ttm)
16.99M CAD
Revenue Growth
+12.03%
P/S Ratio
1.31
Revenue / Employee
849.74K CAD
Employees
20
Market Cap
16.69M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.48M | 2.63M | 18.99% |
| Dec 31, 2023 | 13.85M | 1.07M | 8.33% |
| Dec 31, 2022 | 12.78M | 939.94K | 7.94% |
| Dec 31, 2021 | 11.84M | 799.96K | 7.25% |
| Dec 31, 2020 | 11.04M | 1.50M | 15.74% |
| Dec 31, 2019 | 9.54M | 2.37M | 33.06% |
| Dec 31, 2018 | 7.17M | 1.50M | 26.41% |
| Dec 31, 2017 | 5.67M | -83.19K | -1.45% |
| Dec 31, 2016 | 5.75M | 1.06M | 22.65% |
| Dec 31, 2015 | 4.69M | 475.62K | 11.28% |
| Dec 31, 2014 | 4.22M | -694.11K | -14.14% |
| Dec 31, 2013 | 4.91M | 514.77K | 11.71% |
| Dec 31, 2012 | 4.40M | 442.02K | 11.18% |
| Dec 31, 2011 | 3.95M | 429.37K | 12.18% |
| Dec 31, 2010 | 3.52M | 583.43K | 19.84% |
| Dec 31, 2009 | 2.94M | 985.01K | 50.36% |
| Dec 31, 2008 | 1.96M | 1.44M | 279.05% |
| Dec 31, 2007 | 516.00K | 278.00K | 116.81% |
| Dec 31, 2006 | 238.00K | 211.00K | 781.48% |
| Dec 31, 2005 | 27.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
| CompuMed | 1.69M |
NexgenRx News
- 2 months ago - Nexgenrx declares CAD 0.005 dividend - Seeking Alpha
- 2 months ago - NexgenRx Announces Declaration of Divdends - Accesswire
- 2 months ago - NexgenRx Announces Declaration of Dividends - Accesswire
- 2 months ago - Nexgenrx reports Q3 results - Seeking Alpha
- 3 months ago - NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth - Accesswire
- 6 months ago - NexgenRx declares CAD 0.005 dividend - Seeking Alpha
- 6 months ago - NexgenRx Announces Declaration of Dividend - Accesswire
- 6 months ago - Nexgenrx reports Q2 results - Seeking Alpha